We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
CVS Health today announced the availability of COVID-19 antibody testing at MinuteClinic locations across the country. The point-of-care test can help identify if a patient has previously been
Empirical Spine has secured breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its LimiFlex paraspinous tension band to treat degenerative spondylolisthesis. LimiFlex, which
PerkinElmer company EUROIMMUN has introduced SARS-CoV-2 NeutraLISA assay to determine the neutralising capacity of anti-SARS-CoV-2 antibodies. Part of the firm’s portfolio of Covid-19 diagnostics, the CE-marked surrogate neutralisation
Medical technology firm Becton, Dickinson and Company (BD) is set to invest $65m to build a new 120,000ft² facility in Tucson of Arizona in the US. The new
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance
Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, today announced it has signed an exclusive distribution
Becton, Dickinson and Company (BD) has secured an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its rapid antigen test to screen SARS-CoV-2
Medical technology company Premia Spine has secured breakthrough device designation from the US Food & Drug Administration (FDA) for its TOPS facet arthroplasty system. TOPS is claimed to
OptraSCAN, an end-to-end digital pathology solution provider, has introduced new OS-Ultra 320 high-speed digital pathology scanner. The OS-Ultra 320, which is claimed to be the world’s first high-speed
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received an Emergency